Table 1– MicroRNAs differentially expressed in nonsmall cell lung cancer patients with respect to healthy controls, showing the lowest percentage of false positives

miRNA	Mean fold change (patients versus controls)	ANOVA		SAM analysis
		Unadjusted p-value	False-discovery rate	q-value (%)
hsa-let-7d	0.717536342	0.0227134	0.2336232	2.48
hsa-miR-223	0.724024846	0.0152853	0.2336232	2.89
hsa-miR-383	0.879514588	0.0199543	0.2336232	2.89
hsa-miR-192	0.660891669	0.0579683	0.3794289	2.89
hsa-miR-30e-3p	0.842891622	0.0674752	0.4048513	2.89
hsa-miR-301	0.719256668	0.1026840	0.4496109	2.89
hsa-let-7f	0.537065355	0.1436084	0.4584876	2.48
hsa-miR-572	0.524393644	0.1568791	0.4584876	2.48
hsa-miR-20b	0.698194300	0.1651005	0.4584876	2.89
hsa-miR-345	0.655958424	0.1678559	0.4584876	2.89

SAM: significance analysis of microarrays.